Skip to main content
Pfizer10-K: Digital transformation

Pfizer focused on integrating recent acquisitions Metsera (Nov 2025) and Seagen (Dec 2023).

What happened

With 'Maximize value of key transactions' as a top 2026 priority, Pfizer is under pressure to harmonize the systems, data, and processes from its recent large acquisitions.

Source

SEC EDGARFeb 26, 2026

Annual report (Form 10-K)

Pfizer 10-K for FY2025

Filing excerpt

Our 2026 key priorities are:1.Maximize value of key transactions

sec.gov/Archives/edgar/data/78003/000007800326000026/pfe-20251231.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-K: Digital transformation

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Feb 26, 2026

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
78003
Accession number
0000078003-26-000026
Timeframe
Current year
Filing year
2026
Why it matters
Multi-year tech investment
Signal category
Strategic

Topics and mentions

Vendors

  • Metsera
  • Seagen
  • YaoPharma
  • 3SBio

Extraction

Confidence
High
Relevance
80%
Sentiment
Neutral
Detected
Mar 3, 2026
signal_type
sec-10k
signal_subtype
digitalTransformation

Use this data

Get every 10-K signal for Pfizer and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Pfizer this week?”

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/e30195d7-d3f0-453f-80d6-127649d25f1e returns this record as JSON. POST /v1/companies/enrich returns every signal for pfizer.com.

{
  "signal_id": "e30195d7-d3f0-453f-80d6-127649d25f1e",
  "signal_type": "sec-10k",
  "signal_subtype": "digitalTransformation",
  "detected_at": "2026-03-03T05:50:18.893+00:00",
  "company": {
    "name": "Pfizer",
    "domain": "pfizer.com"
  },
  "data": {
    "detail": "With 'Maximize value of key transactions' as a top 2026 priority, Pfizer is under pressure to harmonize the systems, data, and processes from its recent large acquisitions. This creates significant opportunities for vendors specializing in post-merger IT integration, data migration, ERP/CRM consolidation, and change management.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "Pfizer focused on integrating recent acquisitions Metsera (Nov 2025) and Seagen (Dec 2023).",
    "excerpts": "Our 2026 key priorities are:1.Maximize value of key transactions",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/pfe-20251231.htm",
    "filing_date": "2026-02-26",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Multi-year tech investment",
    "signal_category": "strategic",
    "vendors_mentioned": [
      "Metsera",
      "Seagen",
      "YaoPharma",
      "3SBio"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.